Kliniska studier för KOL i Maryland
16 studier för KOL söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Oxon Hill
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
RekryterarFas 4
Ålder 40 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Baltimore
- Research Site, Baltimore
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Johns Hopkins University, Baltimore
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Baltimore
- Research Site, Potomac
- Research Site, Rosedale
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Baltimore
- Research Site, Columbia
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305STRIVE Post-Market Registry Study
- University of Maryland, Baltimore
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Maryland, Baltimore
- Johns Hopkins, Baltimore
- Tidal Health, Salisbury
RekryterarFas 3
Ålder 40 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT06376994SPIROMICS Study of Early COPD Progression (SOURCE)
- Johns Hopkins Bayview Medical Center, Baltimore
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 30 till 55 · Alla kön · Uppdaterad 3 juni 2026 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Rockville
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 apr. 2026 · NCT06961214OMEGA - Dietary Intervention - COPD Trial
- Johns Hopkins Bayview Campus, Baltimore
Rekryterar
Ålder 40 och äldre · Alla kön · Uppdaterad 16 mars 2026 · NCT05297279Trial to Determine Effective Aspirin Dose in COPD
- Johns Hopkins Bayview Medical Center, Baltimore
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 16 mars 2026 · NCT05265299Effectiveness of the WearME System for COPD Severity and Respiratory Function
- Johns Hopkins, Baltimore
- TidalHealth, Salisbury
RekryterarObservationsstudie
Ålder 21 till 100 · Alla kön · Uppdaterad 9 sep. 2025 · NCT06751537Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Ascension St. Agnes Hospital, Baltimore
RekryterarObservationsstudie
Ålder 50 och äldre · Alla kön · Uppdaterad 5 aug. 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Maryland - Baltimore, Baltimore
Rekryterar
Ålder 30 och äldre · Alla kön · Uppdaterad 6 feb. 2025 · NCT05204888Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.